Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omiganan Phase 2 in Papulopustular Rosacea
NCT01784133Phase 2Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Mar 2013
- Primary completion
- Mar 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omiganan in papulopustular rosacea, sponsored by Maruho Co., Ltd.. Started Mar 2013; status: completed.
02
Drugs
omiganan
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT01784133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01784133.